Comparison of Early Effectiveness of Three Different Intervention Methods in Patients with Chronic Orofacial Pain: A Randomized, Controlled Clinical Trial
Table 3
values of the Wilcoxon signed-rank test.
Question
CT1_vs_CT2
M1T1_vs_M1T2
M2T1_vs_M2T2
Group pretreatment vs posttreatment
1
0.0001
2
0.0001
3
0.0195
0.0781
4
0.0059
0.0050
5
0.0001
6
0.0020
Question
CT1_vs_M1T1
CT1_vs_M2T1
M1T1_vs_M2T1
Pretreatment test
1
0.2893
0.7238
0.3938
2
0.4052
0.8009
0.7080
3
0.1764
0.6621
0.1959
4
0.3440
0.4552
0.8304
5
0.2078
0.2259
0.8820
6
0.6560
0.2617
0.3312
Question
CT2_vs_M1T2
CT2_vs_M2T2
M1T2_vs_M2T2
Posttreatment test
1
0.0035
0.8073
0.0023
2
0.0483
0.7757
0.0196
3
0.5510
0.1758
0.2192
4
0.6726
0.2272
0.1100
5
0.4637
0.0867
0.0348
6
0.1315
0.2529
0.0170
Values are significant at α = 0.05. CT1, control group first test; CT2, control group second test after seven days; M1T1, OA + NSAID group first test; M1T2, OA + NSAID second test after seven days; M2T1, OA + DN group first test; M2T2, OA + DN group second test after seven days; α, significance level.
